Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation and Depletion: 2020-2023

Historic Depreciation and Depletion for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2023 value amounting to $335,000.

  • ADC Therapeutics' Depreciation and Depletion rose 104.27% to $335,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 11.98%. This contributed to the annual value of $1.3 million for FY2024, which is 12.38% up from last year.
  • Per ADC Therapeutics' latest filing, its Depreciation and Depletion stood at $335,000 for Q4 2023, which was up 6.01% from $316,000 recorded in Q3 2023.
  • ADC Therapeutics' Depreciation and Depletion's 5-year high stood at $420,000 during Q2 2021, with a 5-year trough of -$274,000 in Q4 2021.
  • Over the past 3 years, ADC Therapeutics' median Depreciation and Depletion value was $303,000 (recorded in 2022), while the average stood at $263,917.
  • Examining YoY changes over the last 5 years, ADC Therapeutics' Depreciation and Depletion showed a top increase of 159.85% in 2022 and a maximum decrease of 28.81% in 2022.
  • Over the past 4 years, ADC Therapeutics' Depreciation and Depletion (Quarterly) stood at $292,000 in 2020, then skyrocketed by 35.27% to -$274,000 in 2021, then soared by 159.85% to $164,000 in 2022, then surged by 104.27% to $335,000 in 2023.
  • Its Depreciation and Depletion was $335,000 in Q4 2023, compared to $316,000 in Q3 2023 and $273,000 in Q2 2023.